SciSparc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SciSparc and buy or sell other stocks, ETFs, and their options commission-free!About SPRC
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs.
CEOOz Adler
CEOOz Adler
Employees2
Employees2
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2004
Founded2004
Employees2
Employees2
SPRC Key Statistics
Market cap3.52M
Market cap3.52M
Price-Earnings ratio-3.32
Price-Earnings ratio-3.32
Dividend yield—
Dividend yield—
Average volume238.50K
Average volume238.50K
High today$0.3199
High today$0.3199
Low today$0.30
Low today$0.30
Open price$0.31
Open price$0.31
Volume344.11K
Volume344.11K
52 Week high$1.79
52 Week high$1.79
52 Week low$0.197
52 Week low$0.197
People also own
Based on the portfolios of people who own SPRC. This list is generated using Robinhood data, and it’s not a recommendation.